ReviewOncology letters2021
Pembrolizumab in endometrial cancer: Where we stand now.
Aikaterini Aravantinou-Fatorou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewOncology letters2021
Aikaterini Aravantinou-Fatorou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.